Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

2.27
Delayed Data
As of Jul 21
 +0.02 / +0.89%
Today’s Change
1.27
Today|||52-Week Range
7.10
+59.97%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close2.25
Today’s open2.22
Day’s range2.20 - 2.30
Volume90,353
Average volume (3 months)525,768
Market cap$62.5M
Dividend yield--
Data as of 4:02pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-301.25%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.16

Competitors

 Today’s
change
Today’s
% change
SPHSSophiris Bio Inc0.000.00%
CASICASI Pharmaceuticals...-0.03-2.77%
AGLEAeglea Bio Therapeut...+0.08+2.21%
ECYTEndocyte Inc+0.01+0.70%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateAugust 16, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$9.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts